How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...

Recursion Pharmaceuticals (RXRX) shares recently closed at US$3.98, with the stock showing a negative return over the past month and past 3 months, which may prompt investors to reassess its current ...

Oracle-based quantum algorithms cannot use deep loops because quantum states exist only as mathematical amplitudes in Hilbert space with no physical substrate. Criticall ...

Join the founders of Estudio Teddy Cruz + Fonna Forman for a lecture highlighting their dedication to community-engaged research and to the social responsibility of architects and urban planners at ...

Director of the Executive Secretariat of the Lindau Nobel Laureate Meetings. The Lindau Nobel Laureate Meetings bring together about 600 excellent young scientists and 30–40 Nobel laureates every year ...

Join us for this special event with LSE's Philippe Aghion, joint recipient of the 2025 Nobel Memorial Prize in Economic Sciences. This lecture will show how the Schumpeterian growth paradigm can shed ...

UNESCO and the International Association of Universities (IAU) are organizing a series of online lectures on artificial intelligence (AI) and higher education. The monthly lectures are given by ...

The program will consist of a pedagogical series of lectures given over a four-week period, three or four lectures per day, Monday through Friday. The audience will be composed of advanced theoretical ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...